Topicus, PharmaPartners, & VMS Value-Based Pricing
Former Managing Director at Total Specific Solutions
inpractise.com/articles/topicus-pharmapartners-and-vms-value-based-pricing
Why is this interview interesting?
- PharmaPartners core business and customer proposition
- Competition for TSS VMS businesses
- How TSS rolls out value-based pricing for acquired companies
- Extending contract duration to drive customer stickiness
- How to drive recurring revenue in SaaS and Professional Services
- Topicus M&A hurdle rates
- Challenges for long term growth in European VMS
Topicus, PharmaPartners, & VMS Value-Based Pricing(June 30, 2021)
Ben Spaninks
Former Managing Director at Total Specific Solutions
Ben joined TSS in 2015 as a Sales and Marketing Director at PharmaPartners, a TSS portfolio company specialising in EMR software for the Netherlands. He spent 3 years turning around PharmaPartners and pioneered best practices for value-based pricing and organic growth at TSS. Ben then ran Bright Answers, another turnaround within the TSS portfolio, where was reporting to the cofounders of TSS.
Interview Transcript
This is a snippet of the transcript, sign up to read more.
Related Content
Topicus: M&A Strategy & Growth Runway
Former Director at Topicus
Constellation Software: Competition, Hurdle Rates & Deal Flow
Former M&A Executive at Constellation Software
Topicus, TSS, & Dutch Notary Software
Former Managing Director at TSS
Constellation Software Competitive Risks
Former Portfolio Head, M&A at Constellation Software
Copyright Notice
This document may not be reproduced, distributed, or transmitted in any form or by any means including resale of any part, unauthorised distribution to a third party or other electronic methods, without the prior written permission of IP 1 Ltd.
IP 1 Ltd, trading as In Practise (herein referred to as "IP") is a company registered in England and Wales and is not a registered investment advisor or broker-dealer, and is not licensed nor qualified to provide investment advice.
In Practise reserves all copyright, intellectual and other property rights in the Content. The information published in this transcript (“Content”) is for information purposes only and should not be used as the sole basis for making any investment decision. Information provided by IP is to be used as an educational tool and nothing in this Content shall be construed as an offer, recommendation or solicitation regarding any financial product, service or management of investments or securities. The views of the executive expressed in the Content are those of the expert and they are not endorsed by, nor do they represent the opinion of In Practise. In Practise makes no representations and accepts no liability for the Content or for any errors, omissions, or inaccuracies will in no way be held liable for any potential or actual violations of laws, including without limitation any securities laws, based on Information sent to you by In Practise.
© 2023 IP 1 Ltd. All rights reserved.